Erika Elgstrom
Lund, M, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Cytokine evaluation in untreated and radioimmunotherapy-treated tumors in an immunocompetent rat model.
Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
Published: April 07, 2017
Evaluation of immune cell markers in tumor tissue treated with radioimmunotherapy in an immunocompetent rat colon carcinoma model.
Journal: EJNMMI research
Published: June 24, 2015
Sequential radioimmunotherapy with 177Lu- and 211At-labeled monoclonal antibody BR96 in a syngeneic rat colon carcinoma model.
Journal: Cancer biotherapy & radiopharmaceuticals
Published: June 28, 2014
Change in cell death markers during (177)Lu-mAb radioimmunotherapy-induced rejection of syngeneic rat colon carcinoma.
Journal: Cancer biotherapy & radiopharmaceuticals
Published: April 04, 2014
The intratumoral distribution of radiolabeled 177Lu-BR96 monoclonal antibodies changes in relation to tumor histology over time in a syngeneic rat colon carcinoma model.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: June 28, 2013
Successful radioimmunotherapy of established syngeneic rat colon carcinoma with 211At-mAb.
Journal: EJNMMI research
Published: February 08, 2013
Pattern of antigen expression in metastases after radioimmunotherapy of a syngeneic rat colon carcinoma utilizing the BR96 antibody.
Journal: Experimental hematology & oncology
Published: October 24, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026